The European Food Safety Authority (EFSA) has presented a scientific opinion that aims to clarify the safety profile of the food enzyme β‐fructofuranosidase derived from the non-genetically modified Aspergillus sp. strain ATCC 20611. This evaluation is likely to draw the attention of food manufacturers using enzymatic processes, regulatory authorities overseeing food safety, and consumer protection advocates interested in ingredient transparency.
This assessment was published by EFSA's Panel on Food Contact Materials, Enzymes, and Processing Aids on January 12, 2026. The document reflects the authority’s ongoing role in scrutinizing food enzymes to ensure consumer safety within the European Union market.
The document is a scientific opinion rather than binding legislation or policy. It provides an expert evaluation based on toxicological data, manufacturing processes, and usage conditions but stops short of legislative prescriptions. While no explicit numerical targets or deadlines are prescribed, the report includes recommendations on conditions of use, purity criteria, and safety margins.
EFSA’s opinion endorses the enzyme's use under specified conditions, effectively supporting continued or new applications of β‐fructofuranosidase in food processing. This reflects a regulatory stance that balances innovation in enzymatic food technologies with cautionary principles to protect consumers. The evaluation neither proposes increasing nor decreasing regulatory powers but instead strengthens the supervisory role by detailing safety requirements and recommended operational parameters.
The industry stakeholders, primarily food producers and enzyme manufacturers, stand to benefit from clarity on the enzyme's safe usage, enabling product development with fewer uncertainties. Regulatory authorities gain from refined safety benchmarks, improving the consistency of market surveillance. Conversely, some producers may face higher compliance costs to meet recommended purity and usage guidelines, while consumer groups gain reassurance due to the scientific backing for safety claims.
This EFSA opinion represents a continuation of its standard evaluation framework aimed at harmonizing food enzyme safety oversight across the EU. It is expected that national food safety agencies and the European Commission will consider this scientific advice when updating authorizations or guidance, thus potentially influencing future regulatory measures or market approvals.